Compounds for targeting mutant huntingtin protein and uses thereof
US12083108B2 · kind B2 · utility
0Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2022 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | May 24, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to compounds that simultaneously bind both mutant huntingtin protein (mHTT) and an ubiquitin E3 ligase and their use as therapeutic agents, for example, in treating diseases, such as neurodegenerative disorders caused by aggregation of mHTT.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.